JP2025503646A5 - - Google Patents

Info

Publication number
JP2025503646A5
JP2025503646A5 JP2024541193A JP2024541193A JP2025503646A5 JP 2025503646 A5 JP2025503646 A5 JP 2025503646A5 JP 2024541193 A JP2024541193 A JP 2024541193A JP 2024541193 A JP2024541193 A JP 2024541193A JP 2025503646 A5 JP2025503646 A5 JP 2025503646A5
Authority
JP
Japan
Application number
JP2024541193A
Other languages
Japanese (ja)
Other versions
JP2025503646A (ja
JPWO2023131920A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2023/050170 external-priority patent/WO2023131920A1/en
Publication of JP2025503646A publication Critical patent/JP2025503646A/ja
Publication of JP2025503646A5 publication Critical patent/JP2025503646A5/ja
Publication of JPWO2023131920A5 publication Critical patent/JPWO2023131920A5/ja
Pending legal-status Critical Current

Links

JP2024541193A 2022-01-10 2023-01-09 うつ病の治療のための組成物及び方法 Pending JP2025503646A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263298047P 2022-01-10 2022-01-10
US63/298,047 2022-01-10
PCT/IB2023/050170 WO2023131920A1 (en) 2022-01-10 2023-01-09 Compositions and methods for the treatment of depression

Publications (3)

Publication Number Publication Date
JP2025503646A JP2025503646A (ja) 2025-02-04
JP2025503646A5 true JP2025503646A5 (https=) 2026-01-16
JPWO2023131920A5 JPWO2023131920A5 (https=) 2026-01-16

Family

ID=84981555

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024541193A Pending JP2025503646A (ja) 2022-01-10 2023-01-09 うつ病の治療のための組成物及び方法

Country Status (10)

Country Link
US (1) US20250221960A1 (https=)
EP (1) EP4463152A1 (https=)
JP (1) JP2025503646A (https=)
KR (1) KR20240132479A (https=)
CN (1) CN118510507A (https=)
AU (1) AU2023205471A1 (https=)
CA (1) CA3247760A1 (https=)
IL (1) IL314179A (https=)
MX (1) MX2024008618A (https=)
WO (1) WO2023131920A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024336807A1 (en) * 2023-09-06 2026-04-16 Janssen Pharmaceuticals, Inc. Compositions comprising aticaprant for use in treating major depressive disorder

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5345637B2 (ja) * 2008-01-22 2013-11-20 イーライ リリー アンド カンパニー κ選択的オピオイド受容体アンタゴニスト

Similar Documents

Publication Publication Date Title
JP2025503646A5 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY23965C1 (https=)
BY13164U (https=)
BY13140U (https=)
BY13174U (https=)
BY13172U (https=)
BY13170U (https=)
BY13169U (https=)
BY13137U (https=)
BY13135U (https=)
BY13143U (https=)